Newron Pharmaceuticals’ add-on schizophrenia treatment improved both positive and negative symptoms as well as severity in patients with the disorder during a phase 2/3 study. The Italian biotech is ...
Schizophrenia is a serious mental disorder involving changes in perception, thoughts, and behaviors. It typically involves a disconnection from reality, in which a person experiences hallucinations ...
German drugmaker Boehringer Ingelheim and Click Therapeutics said their phase 3 trial of a prescription digital therapeutic for the negative symptoms of schizophrenia met its primary endpoint. Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback